Larvol Delta - FDA-Grants-Orphan-Drug-Designation-for-BE101-a-Novel-Engineered-B-Cell-Medicine-for-the-Treatment-of-Hemophilia-B

BE-101 - Be Biopharma

https://www.businesswire.com/news/home/20240604306493/en/FDA-Grants-Orphan-Drug-Designation-for-BE-101-a-Novel-Engineered-B-Cell-Medicine-for-the-Treatment-of-Hemophilia-B

Jun 4, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next